Xillix forms image cytometry company:
This article was originally published in Clinica
Canadian company Xillix is creating a wholly-owned subsidiary, Oncometrics Imaging, to focus on automated image cytometry for the detection and assessment of early cancer. Xillix will devote attention to the Life imaging system technology. Private funding of up to Can$10 million will be sought for Oncometrics which will be headed by Dr Branko Palcic, a founder and chief scientist of Xillix. Oncometrics will remain a private company.